You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康-B(6606.HK)高開近7% 旗下幽幽管今日全網首發
格隆匯 01-18 09:22
格隆匯1月18日丨諾輝健康-B(6606.HK)高開近7%報30.05港元,市值129億港元。諾輝健康旗下幽門螺桿菌消費者自測產品幽幽管今日首發!凌晨已全面上線京東、愛康、美團買藥、天貓、平安健康、樂薦幾大電商平台。幽幽管於2022年1月6日獲得國家藥品監督管理局(NMPA)批准的三類醫療器械註冊申請。這是國家藥監局批准的中國首個適用於“消費者自測”的幽門螺桿菌檢測產品。據悉,幽幽管首次實現取樣和檢測“驗孕棒”式一體化設計,用户操作簡單,無痛無創,檢測前無需服藥,檢測時無需空腹,對樣本採集無特殊要求,採樣後將取樣棒插回試劑管,10秒搖勻,按下管蓋後10分鐘即可讀取結果,經國家藥監局督導的註冊臨牀試驗驗證,充分達到了“消費者自測”需要的準確安全和便捷性要求。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account